GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulmonx Corp (STU:4NI) » Definitions » Accounts Payable

Pulmonx (STU:4NI) Accounts Payable : €2.96 Mil (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Pulmonx Accounts Payable?

Pulmonx's Accounts Payable for the quarter that ended in Jun. 2024 was €2.96 Mil.

Pulmonx's quarterly Accounts Payable increased from Dec. 2023 (€1.37 Mil) to Mar. 2024 (€2.88 Mil) and increased from Mar. 2024 (€2.88 Mil) to Jun. 2024 (€2.96 Mil).

Pulmonx's annual Accounts Payable increased from Dec. 2021 (€1.40 Mil) to Dec. 2022 (€1.66 Mil) but then declined from Dec. 2022 (€1.66 Mil) to Dec. 2023 (€1.37 Mil).


Pulmonx Accounts Payable Historical Data

The historical data trend for Pulmonx's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulmonx Accounts Payable Chart

Pulmonx Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
Get a 7-Day Free Trial 2.41 1.21 1.40 1.66 1.37

Pulmonx Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.19 2.99 1.37 2.88 2.96

Pulmonx Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Pulmonx Accounts Payable Related Terms

Thank you for viewing the detailed overview of Pulmonx's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Pulmonx Business Description

Traded in Other Exchanges
Address
700 Chesapeake Drive, Redwood, CA, USA, 94063
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the U.S. and international markets.

Pulmonx Headlines

No Headlines